BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, June 22, 2026
Home » Authors » John Fox

John Fox

Articles

ARTICLES

First rotaviruses derived entirely from cloned DNA developed

Feb. 10, 2017
By John Fox
The first successful recovery of recombinant rotaviruses (RVs) derived entirely from cloned cDNAs in a Japanese study will both improve understanding of RV pathobiology and promote the development of new vaccines and therapeutics.
Read More

Inhibitors join in vivo optogenetic toolbox

Feb. 1, 2017
By John Fox
A study by researchers in Singapore has identified optogenetic inhibitors of brain activity and successfully demonstrated their efficacy in a Drosophila melanogaster fruit fly model, which should improve our understanding of the relationship between neural circuits and behavior.
Read More

Inhibitors join in vivo optogenetic toolbox

Jan. 31, 2017
By John Fox
A study by researchers in Singapore has identified optogenetic inhibitors of brain activity and successfully demonstrated their efficacy in a Drosophila melanogaster fruit fly model, which should improve our understanding of the relationship between neural circuits and behavior.
Read More

Plant-derived products may help fight HBV

Jan. 25, 2017
By John Fox
A plant-derived compound and its analogues may help prevent and treat hepatitis B virus (HBV) infection and could contribute to the development of well-tolerated and broadly active inhibitors of HBV, including activity against treatment-resistant strains, a new Japanese study has found.
Read More

Plant-derived products may help fight HBV

Jan. 25, 2017
By John Fox
A plant-derived compound and its analogues may help prevent and treat hepatitis B virus (HBV) infection and could contribute to the development of well-tolerated and broadly active inhibitors of HBV, including activity against treatment-resistant strains, a new Japanese study has found.
Read More

New targets for overcoming melanoma resistance identified

Jan. 18, 2017
By John Fox
HONG KONG – A study by Japanese researchers has identified two promising and selective candidate therapeutic targets that could prove important in the development of new treatments aimed at overcoming drug resistance in melanoma.
Read More

New targets for overcoming melanoma resistance identified

Jan. 18, 2017
By John Fox
HONG KONG – A study by Japanese researchers has identified two promising and selective candidate therapeutic targets that could prove important in the development of new treatments aimed at overcoming drug resistance in melanoma.
Read More

Stem cell-based model suggests deafness treatments

Jan. 13, 2017
By John Fox
Researchers at Tokyo's Keio University School of Medicine have developed the first in vitro cochlear cell model using patient-derived disease-specific human induced pluripotent stem cells (hiPSCs), which allows study of the pathogenesis of congenital deafness and may lead to its treatment.
Read More

Stem cell strategy boosts testosterone

Jan. 11, 2017
By John Fox
Researchers at Jinan University in Guangzhou, China, have developed the first stem cell-based treatment strategy for androgen deficiency due to male hypogonadism, whereby adult rodent skin cells are directly converted into functional testosterone-producing Leydig-like cells.
Read More

Stem cell strategy boosts testosterone

Jan. 4, 2017
By John Fox

Researchers at Jinan University in Guangzhou, China, have developed the first stem cell-based treatment strategy for androgen deficiency due to male hypogonadism, whereby adult rodent skin cells are directly converted into functional testosterone-producing Leydig-like cells.


Read More
View All Articles by John Fox

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 18, 2026.
  • Alicorn synthesizes new AAK1 inhibitors

    BioWorld Science
    Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
  • Illustration of glucose in the blood stream

    CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research

    BioWorld Science
    Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
  • Illustration of a child's brain

    Saniona reports preclinical data for SAN-2668

    BioWorld Science
    Saniona AB has presented preclinical data and its clinical development strategy for its lead clinical candidate, SAN-2668, which is a GABA-A receptor positive...
  • CC-3 antibody shows antitumoral activity in penile cancer

    BioWorld Science
    Advanced penile cancer (PeCa) is a rare cancer affecting the genitourinary tract with a 5-year survival rate of about 10% when metastatic. First-line therapies...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing